Latest valuation a jump from $100 billion in August Databricks surpasses $4.8 billion revenue run rate in Q3 Funds to be used to expand research and for talent retention Company delivers positive free ...

Instead of recommending the hepatitis B vaccine for all newborns, the Centers for Disease Control and Prevention now officially advises women who test negative for the virus to consult health care ...

Four months after its last funding round, Databricks Inc. today announced that it has closed an extremely late-stage investment worth more than $4 billion. The Series L round was jointly led by ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Here's where the San Francisco ...

(Bloomberg/Mark Bergen and Brody Ford) — Databricks is raising over $4 billion in a new funding round that values the software firm at $134 billion, another example of how some tech companies are ...

The IPO window may have cracked open, but it seems some former startups have no intention of going public. Makes sense, in a way: IPOs were traditionally a way to raise money, and if you can manage to ...

Databricks is raising over $4 billion in Series L funding that would value the data-analytics and artificial-intelligence software company at $134 billion, an increase of 34% from its last funding ...

California Gov. Gavin Newsom (D) announced Monday he is hiring two former top officials from the Centers for Disease Control and Prevention (CDC) who were pushed out by Health and Human Services ...

There is no shortage of AI benchmarks in the market today, with popular options like Humanity's Last Exam (HLE), ARC-AGI-2 and GDPval, among numerous others. AI agents excel at solving abstract math ...

In a chaotic meeting Thursday rife with misinformation, the CDC’s vaccine advisory panel — whose members Health Secretary Robert F. Kennedy Jr. fired in June and replaced with a group that has largely ...

Daskalakis is the former director of the CDC’s National Center for Immunization and Respiratory Diseases and is principal at Dr Demetre Consulting. Jernigan is the former director of the CDC’s ...